A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

Clinical trial NCT07644559 · RECRUITING

Trial details

NCT number: NCT07644559
Sponsor: Verastem, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma (PDAC)G12D Mutated KRAS

Start date: 2026-06-16
Primary completion: 2027-06-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.